Hsa-miR-326 Targets CCND1 and Inhibits Non-Small Cell Lung Cancer Development
Oncotarget - United States
doi 10.18632/oncotarget.7071
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 29, 2016
Authors
Publisher
Impact Journals, LLC